Global Oral Solid Dosage Contract Manufacturing Market by Product (Capsules, Granules, Gummies), Mechanism (Controlled-Release, Delayed-Release, Immediate-Release), End-User - Forecast 2024-2030- Product Image

Sale

Global Oral Solid Dosage Contract Manufacturing Market by Product (Capsules, Granules, Gummies), Mechanism (Controlled-Release, Delayed-Release, Immediate-Release), End-User - Forecast 2024-2030

Report
190 Pages
March 2024
Region: Global
360iResearch™
ID: 5666205

UP TO €853EUR$875USD£729GBP OFF until Dec 31^st 2024

The Oral Solid Dosage Contract Manufacturing Market size was estimated at USD 40.83 billion in 2023, USD 44.16 billion in 2024, and is expected to grow at a CAGR of 8.63% to reach USD 72.91 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Oral Solid Dosage Contract Manufacturing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Oral Solid Dosage Contract Manufacturing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Oral Solid Dosage Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Aenova Holding GmbH, Alcami Corporation, Inc., Aphena Pharma Solutions, Ardena Holding NV, Boehringer Ingelheim International GmbH, Cambrex Corporation, Corden Pharma International GmbH, GlaxoSmithKline PLC, Hermes Pharma GmbH, Jubilant Pharma Holdings Inc., Lonza Group Ltd., Novartis AG, Pfizer Inc., Piramal Group, and Recipharm AB.

Market Segmentation & Coverage

This research report categorizes the Oral Solid Dosage Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product
- Capsules
- Granules
- Gummies
- Lozenges
- Pastilles
- Powders
- Tablets
Mechanism
- Controlled-Release
- Delayed-Release
- Immediate-Release
End-User
- Large-Size Companies
- Medium- & Small-Size Companies
- Startups & Generic Pharmaceutical Companies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Oral Solid Dosage Contract Manufacturing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Oral Solid Dosage Contract Manufacturing Market?
What are the technology trends and regulatory frameworks in the Oral Solid Dosage Contract Manufacturing Market?
What is the market share of the leading vendors in the Oral Solid Dosage Contract Manufacturing Market?
Which modes and strategic moves are suitable for entering the Oral Solid Dosage Contract Manufacturing Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Oral Solid Dosage Contract Manufacturing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of outsourcing services by pharmaceutical companies
5.1.1.2. Increasing patent expiration and generic drug manufacturing
5.1.1.3. Need for cost-effective drug development process
5.1.2. Restraints
5.1.2.1. Less availability of experienced technical staff
5.1.3. Opportunities
5.1.3.1. Increase in the advancement of drug development technology
5.1.3.2. Rising investments by CDMOs to expand the oral solid dosage (OSD) development
5.1.4. Challenges
5.1.4.1. Strict approval criteria by regulatory authorities
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Oral Solid Dosage Contract Manufacturing Market, by Product

6.1. Introduction
6.2. Capsules
6.3. Granules
6.4. Gummies
6.5. Lozenges
6.6. Pastilles
6.7. Powders
6.8. Tablets

7. Oral Solid Dosage Contract Manufacturing Market, by Mechanism

7.1. Introduction
7.2. Controlled-Release
7.3. Delayed-Release
7.4. Immediate-Release

8. Oral Solid Dosage Contract Manufacturing Market, by End-User

8.1. Introduction
8.2. Large-Size Companies
8.3. Medium- & Small-Size Companies
8.4. Startups & Generic Pharmaceutical Companies

9. Americas Oral Solid Dosage Contract Manufacturing Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Oral Solid Dosage Contract Manufacturing Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Oral Solid Dosage Contract Manufacturing Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Aenova Holding GmbH
13.1.2. Alcami Corporation, Inc.
13.1.3. Aphena Pharma Solutions
13.1.4. Ardena Holding NV
13.1.5. Boehringer Ingelheim International GmbH
13.1.6. Cambrex Corporation
13.1.7. Corden Pharma International GmbH
13.1.8. GlaxoSmithKline PLC
13.1.9. Hermes Pharma GmbH
13.1.10. Jubilant Pharma Holdings Inc.
13.1.11. Lonza Group Ltd.
13.1.12. Novartis AG
13.1.13. Pfizer Inc.
13.1.14. Piramal Group
13.1.15. Recipharm AB
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
FIGURE 3. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET DYNAMICS
FIGURE 7. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 8. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2023 VS 2030 (%)
FIGURE 10. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY GUMMIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY LOZENGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PASTILLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 14. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY CONTROLLED-RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY DELAYED-RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY IMMEDIATE-RELEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 18. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY LARGE-SIZE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MEDIUM- & SMALL-SIZE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STARTUPS & GENERIC PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. CANADA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 33. CANADA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. MEXICO ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 36. MEXICO ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. CHINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 50. CHINA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. INDIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 53. INDIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. JAPAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 59. JAPAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. THAILAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 77. THAILAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. DENMARK ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 87. DENMARK ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. EGYPT ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 90. EGYPT ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. FINLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 93. FINLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 96. FRANCE ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. GERMANY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 99. GERMANY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. ITALY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 105. ITALY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. NORWAY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 114. NORWAY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. POLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 117. POLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. QATAR ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 120. QATAR ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SPAIN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 132. SPAIN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. TURKEY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 141. TURKEY ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY MECHANISM, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET LICENSE & PRICING

Companies Mentioned

Aenova Holding GmbH
Alcami Corporation, Inc.
Aphena Pharma Solutions
Ardena Holding NV
Boehringer Ingelheim International GmbH
Cambrex Corporation
Corden Pharma International GmbH
GlaxoSmithKline PLC
Hermes Pharma GmbH
Jubilant Pharma Holdings Inc.
Lonza Group Ltd.
Novartis AG
Pfizer Inc.
Piramal Group
Recipharm AB

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	190
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 44.16 Billion
Forecasted Market Value ( USD ) by 2030	$ 72.91 Billion
Compound Annual Growth Rate	8.6%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3291EUR$3,374USD£2,810GBP €3657EUR$3,749USD£3,122GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4169EUR$4,274USD£3,560GBP €4632EUR$4,749USD£3,955GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5047EUR$5,174USD£4,309GBP €5608EUR$5,749USD£4,788GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5925EUR$6,074USD£5,059GBP €6583EUR$6,749USD£5,621GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7681EUR$7,874USD£6,558GBP €8534EUR$8,749USD£7,286GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product Type (Tablets, Capsules, Powders, Granules), Mechanism, End-use, Region, and Segment Forecasts, 2024-2030

Global Oral Solid Dosage Contract Manufacturing Market by Product Type, by Mechanism, by End-User, and By Region

Oral Solid Dosage Contract Manufacturing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Oral Solid dosage (OSD) Contract Manufacturing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Global High Potency API Contract Manufacturing Market by Product Type (Generics, Innovative), Synthesis (Biotech, Synthetic), Dosage Form, Application - Forecast 2024-2030

About the Oral Solid Dosage Contract Manufacturing Market